NCT05106218

Brief Summary

The aim of this study is to evaluate standard urological surgeries using the 270Surgical system vs same procedures using the standard scope

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

November 3, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

February 9, 2022

Status Verified

November 1, 2021

Enrollment Period

9 months

First QC Date

October 7, 2021

Last Update Submit

February 8, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Analysis of the efficient work time with the standard scope and the SurroundScope - Time of surgery

    Data collected include - skin to skin time of surgery

    During the surgery - Since the first incision performed till the last incision is closed

  • Analysis of the efficient work time with the standard scope and the SurroundScope - tools and ports Visibility time

    Data collected include - Visibility time of tools and ports in the Field of view

    During the surgery - Since the first incision performed till the last incision is closed

  • Analysis of the efficient work time with the standard scope and the SurroundScope - time of scope removals

    Data collected include - Time of scope removals during the case to clear smoke or fog

    During the surgery - Since the first incision performed till the last incision is closed

Secondary Outcomes (3)

  • Time of defined surgical tasks - port placement time

    During the defined surgical task

  • Time of defined surgical tasks - transection time

    During the defined surgical task

  • Time of defined surgical tasks - clamp time

    During the defined surgical task

Other Outcomes (3)

  • Adverse events

    During the surgery - Since the first incision performed till the last incision is closed

  • Length of stay

    Since the surgery completion to discharge from the medical center

  • Surgeon's perception 270surgical

    Immediately following the surgery is completed

Study Arms (2)

SurroundScope

EXPERIMENTAL

For laparoscopic camera system, the SurroundScope, 270-degree angle videoscope (270Surgical, Israel) is used

Device: SurroundScope

Standard laparoscope

ACTIVE COMPARATOR

For laparoscopic camera system, the Standard laparoscope that is in a standard use at the medical center is used

Device: Standard Laparoscope

Interventions

The procedure will be performed according to the institution's standard of care, using the SurroundScope for visualization.

Also known as: 270System
SurroundScope

The procedure will be performed according to the institution's standard of care, using the Standard laparoscope for visualization.

Standard laparoscope

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than or equal to 18
  • Capable of giving informed consent.
  • Scheduled for laparoscopic urologic surgery: Partial nephrectomy, Nephrectomy

You may not qualify if:

  • Unfit for surgery: concomitant disorders incompatible with the study or surgery (at the discretion of the investigator)
  • Patients with contraindications to undergo laparoscopic surgery.
  • Patients with American Society of Anesthesiology (ASA) class\* \>3
  • Advanced cirrhosis with failure of hepatic function
  • Patients who have participated in another interventional clinical study in the last month.
  • Pregnancy
  • Unable to consent (due to cultural, language or neurological barriers)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rabin Medical Center

Petah Tikva, 49100, Israel

Location

Study Officials

  • Andrew Nado, MD

    Rabin Medical Center, 39 Jabotinski St., Petah Tikva 49100

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients are not aware of the laparoscopic system that will be used during the operation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: For laparoscopic camera system to be used in urological surgeries, the SurroundScope, 270-degree angle videoscope (270Surgical, Israel) is used. This will be compared to the standard laparoscopic system use. The study will evaluate standard urological surgeries using the 270Surgical system vs same procedures using the standard scope. The procedure will be performed according to the institution's standard of care, using the SurroundScope or the standard scope for visualization. Each surgery will be captured on video.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2021

First Posted

November 3, 2021

Study Start

March 1, 2022

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

February 9, 2022

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations